Mirjana Drinic

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Biomimetic, Silaffin R5-Based Antigen Delivery Platform.

A Biomimetic, Silaffin R5-Based Antigen Delivery Platform.

Journal: Pharmaceutics

Published: November 28, 2022

Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer.

Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer.

Journal: Cancers

Published: October 12, 2022

Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model.

Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model.

Journal: Translational oncology

Published: February 14, 2022

Vaccination against Her-2/neu, with focus on peptide-based vaccines.

Vaccination against Her-2/neu, with focus on peptide-based vaccines.

Journal: ESMO open

Published: November 03, 2021

Emerging targets for anticancer vaccination: PD-1.

Emerging targets for anticancer vaccination: PD-1.

Journal: ESMO open

Published: July 26, 2021

Reduction of Allergic Lung Disease by Mucosal Application of Toxoplasma gondii-Derived Molecules: Possible Role of Carbohydrates.

Reduction of Allergic Lung Disease by Mucosal Application of Toxoplasma gondii-Derived Molecules: Possible Role of Carbohydrates.

Journal: Frontiers in immunology

Published: September 30, 2020

Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.

Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 22, 2020

A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.

A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.

Journal: Frontiers in immunology

Published: December 15, 2019

Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro.

Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro.

Journal: International journal for parasitology. Drugs and drug resistance

Published: November 16, 2018

Correction: E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.

Correction: E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.

Journal: Mucosal immunology

Published: November 03, 2018

E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.

E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.

Journal: Mucosal immunology

Published: March 02, 2018

Prophylactic and therapeutic inhibition of allergic airway inflammation by probiotic Escherichia coli O83.

Prophylactic and therapeutic inhibition of allergic airway inflammation by probiotic Escherichia coli O83.

Journal: The Journal of allergy and clinical immunology

Published: December 12, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026